Cytomx Therapeutics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$4.24

-0.22 (-4.93%)

As of Mar 24, 10:03 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 13 87%

Hold 2 13%

Sell 0 0%

Price Target

Analyst Price Target +1,386.8% upside

Low Target $39.26

Average Target $63.04

High Target $88.15

Current Price $4.24

Current
$4.24

Target
$63.04

$39.26 $63.04 avg $88.15

Scenario Analysis

Bear Case

$39.26

825.9%

Low target

Base Case

$63.04

+1,386.8%

Avg target

Bull Case

$88.15

+1,979.0%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$6.35

-33.2% from high

52-Week Low

$0.40

+960.0% from low

Target vs 52W High

$63.04

+892.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%